Deutsche Medizinische Wochenschrift
1986-12-19
[Phosphodiesterase inhibition as a new positive-inotropic principle].
A Hartmann, M Saeed, G Sütsch, R J Bing
Index: Dtsch. Med. Wochenschr. 111(51-52) , 1971-7, (1986)
Full Text: HTML
Abstract
Related Articles:
New mechanisms for positive inotropic agents: focus on the discovery and development of imazodan.
1989-03-01
[Cardiovasc. Drugs Ther. 3(1) , 29-42, (1989)]
Determination of 4,5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinone hydrochloride, a new cardiotonic, in plasma and urine by reversed-phase high-performance liquid chromatography.
[J. Chromatogr. A. 336(2) , 446-51, (1984)]
Effect of a new phosphodiesterase type III inhibitor as a coronary vasodilator and positive inotropic agent.
1987-08-01
[Cardiovasc. Res. 21(8) , 593-600, (1987)]
Inotropic and chronotropic profile of MCI-154: comparison with isoproterenol and imazodan in guinea pig cardiac preparations.
1990-07-01
[J. Cardiovasc. Pharmacol. 16(1) , 59-67, (1990)]
Effects of CI-914 in congestive heart failure due to coronary artery disease or idiopathic cardiomyopathy.
1986-09-15
[Am. J. Cardiol. 58(7) , 596-600, (1986)]